Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Glioblastoma 44Glioma 16Melanoma 11Central Nervous System Neoplasms 11Astrocytoma 11Brain Neoplasms 10Oligodendroglioma 7Gliosarcoma 5Small Cell Lung Carcinoma 4Recurrence 3Lymphoma 3Leiomyosarcoma 3Sarcoma 2Neoplasms, Neuroepithelial 2Neoplasms 2Neoplasm Metastasis 2Ependymoma 2Diffuse Intrinsic Pontine Glioma 2Breast Neoplasms 2Uveal Melanoma 1Seizures 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma, Endometrial Stromal 1Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Recurrent Extensive Stage Small Cell Lung Carcinoma 1Rectal Neoplasms 1Pituitary Neoplasms 1

Interventions

Radiation Dose Hypofractionation 2toripalimab 1lentiviral minigene vaccine of COVID-19 coronavirus 1envafolimab 1brostallicin 1anlotinib 1Temozolomide 1Ritonavir 1Radiotherapy 1Phlebotomy 1Molecular Diagnostic Techniques 1Microarray Analysis 1Ipilimumab 1Indinavir 1Doxorubicin 1Diathermy 1Blood Specimen Collection 1Biopsy, Needle 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Histiocytoma, Malignant Fibrous × Temozolomide × Clear all
NCT00003718 2014-01-06

Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 2 Unknown
25 enrolled
GynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡